High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases

BACKGROUND: Patients with borderline resectable colorectal liver metastases (CRLM) frequently receive neoadjuvant chemotherapy (NC) to reduce tumour burden, thus making surgical resection feasible. Even though NC can induce severe liver injury, most studies investigating tissue-based prognostic mark...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Cancer
Main Authors: Strowitzki, Moritz J., Radhakrishnan, Praveen, Pavicevic, Sandra, Scheer, Jana, Kimmer, Gwendolyn, Ritter, Alina S., Tuffs, Christopher, Volz, Claudia, Vondran, Florian, Harnoss, Jonathan M., Klose, Johannes, Schmidt, Thomas, Schneider, Martin
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6461828/
https://ncbi.nlm.nih.gov/pubmed/30808993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0406-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki